Evaluation of Analgesia by PENG Block Versus Intra-Articular Infiltration in Prosthetic Hip Surgery (API)
Not Applicable
Completed
- Conditions
- AnalgesiaPENG BlockHip Prosthesis
- Interventions
- Procedure: Prosthetic hip surgery
- Registration Number
- NCT05250492
- Lead Sponsor
- Ramsay Générale de Santé
- Brief Summary
The main objective of this study is to compare the effectiveness of the ultrasound-guided PENG block technique compared to intra-articular infiltration on postoperative morphine consumption during hip prosthetic surgery via the anterior minimally invasive approach under general anesthesia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Patient, male or female, over 18 years old.
- Patient scheduled for anterior hip prosthesis.
- Affiliated patient or beneficiary of a social security scheme.
- Patient having been informed and having signed a free and informed consent.
Exclusion Criteria
- Patient with a contraindication to local anesthesia.
- Patient with a high level of dependence, defined by level 1 or 2 of the Iso-Ressources Group (GIR).
- Patient participating in another clinical study.
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of freedom by judicial or administrative decision.
- Pregnant, breastfeeding or parturient woman.
- Patient hospitalized without consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Patients with intra-articular infiltration Prosthetic hip surgery - Patients with PENG block Prosthetic hip surgery -
- Primary Outcome Measures
Name Time Method Postoperative morphine consumption in the postoperative care unit 1 hour Postoperative morphine consumption (in mg) in the postoperative care unit
- Secondary Outcome Measures
Name Time Method Postoperative morphine équivalent consumption at postoperative day 1 1 day postoperative morphine équivalent consumption (in mg) at postoperative day 1
Trial Locations
- Locations (1)
Jean-François Oudet
🇫🇷Lanester, France